Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

Por Outterson, Kevin, Gopinathan, Unni, Clift, Charles, So, Anthony D., Morel, Chantal M., Røttingen, John-Arne
Publicado no PLoS Med (2016)

Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations

Por Årdal, Christine, Baraldi, Enrico, Theuretzbacher, Ursula, Outterson, Kevin, Plahte, Jens, Ciabuschi, Francesco, Røttingen, John-Arne
Publicado no J Pharm Policy Pract (2018)

An international legal framework to address antimicrobial resistance

Por Hoffman, Steven J, Outterson, Kevin, Røttingen, John-Arne, Cars, Otto, Clift, Charles, Rizvi, Zain, Rotberg, Fiona, Tomson, Göran, Zorzet, Anna
Publicado no Bull World Health Organ (2015)

Introduction and geographic availability of new antibiotics approved between 1999 and 2014

Por Kållberg, Cecilia, Årdal, Christine, Salvesen Blix, Hege, Klein, Eili, M. Martinez, Elena, Lindbæk, Morten, Outterson, Kevin, Røttingen, John-Arne, Laxminarayan, Ramanan
Publicado no PLoS One (2018)